Quantcast
Novartis aims to bottle more than 50 million doses of BioNTech COVID-19 vaccine in 2021 - Metro US

Novartis aims to bottle more than 50 million doses of BioNTech COVID-19 vaccine in 2021

FILE PHOTO: Logo is seen at new factory of Novartis in Stein

ZURICH (Reuters) – Novartis aims to help manufacture more than 50 million doses of BioNTech’s COVID-19 vaccine in 2021 at its Stein, Switzerland fill-and-finish facility, the Swiss drugmaker said, after the European Union’s drug regulator approved the bottling plant.

(Reporting by John Miller; Editing by Chris Reese)

More from our Sister Sites